Since THZ1 treatment effectively reduced MYC and inhibited the proliferation as well as induced the apoptosis of the cultured HCC cells, we next assessed in vivo CDK7 inhibition in a mouse HepG2 xenograft tumor model. This evidence concerns the gene CDK7 and hepatocellular carcinoma.